Consequences of bacterial CpG DNA-driven activation of antigen-presenting cells.
Sparwasser
T
T
Institute of Medical Microbiology, Immunology and Hygiene, Technical University Munich, Germany.
Lipford
G B
GB
D000276:Adjuvants, Immunologic; D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology*; D018899:CpG Islands / Q000276:immunology*; D004269:DNA, Bacterial / Q000276:immunology* / Q000627:therapeutic use; D003713:Dendritic Cells / Q000276:immunology; D006801:Humans; D008262:Macrophage Activation / Q000276:immunology; D012772:Shock, Septic / Q000276:immunology / Q000503:physiopathology; D018418:Th2 Cells / Q000276:immunology
D000276:Adjuvants, Immunologic; D004269:DNA, Bacterial